Loading...
Business Development Manager, Facial Aesthetics - San Diego North at Abbvie
AbbvieSan Diego, CA, us·9h ago
Entry LevelFull-time
Salary Range
$25,500 - $34,500 /year
This salary is estimated based on similar roles. The actual salary may vary.
About the Role
We are seeking a Business Development Manager to represent the Facial Aesthetics product portfolio to targeted aesthetic customers. This role focuses on creating product acceptance and enhancing portfolio growth through business development activities.
Key Responsibilities
- →Represent the Facial Aesthetics product portfolio to targeted aesthetic customers
- →Create product acceptance and enhance portfolio growth through business development activities
- →Provide technical product and procedure expertise
- →Differentiate our products from competitors
- →Achieve assigned sales goals through creative, consultative selling
- →Implement the U.S. Sales/Marketing plan
- →Leverage resources to accelerate the adoption and sales growth of the Facial Aesthetics portfolio
- →Coordinate activities with other Allergan Aesthetics cross portfolio partners and support teams
- →Comply with required reporting, requests, and compliance policies
Requirements
- ✓Experience in business development or sales within the aesthetic industry
- ✓Strong understanding of Facial Aesthetics products and procedures
- ✓Excellent communication and consultative selling skills
- ✓Ability to meet sales targets and implement marketing plans
- ✓Knowledge of compliance policies and reporting requirements
Free to sign up. Takes 30 seconds.
About Abbvie
Abbvie is a global biopharmaceutical company specializing in the research, development, and commercialization of innovative therapies. Headquartered in North Chicago, Illinois, the company was founded in 2013 following the spin-off of Abbott Laboratories' pharmaceutical division. Abbvie operates at the forefront of the biotechnology and pharmaceutical industries, focusing on addressing complex diseases and improving patient outcomes through scientific advancement. The company's primary products include treatments for immunology, oncology, and neurology, with its flagship drug, Humira, being one of the best-selling medications globally. Abbvie is known for its robust pipeline of investigational therapies, leveraging cutting-edge research and clinical trials to bring novel treatments to market. Its target audience includes patients, healthcare providers, and payers, with a particular emphasis on those suffering from chronic and life-threatening conditions. Key features of Abbvie's offerings include targeted therapies, personalized medicine approaches, and a commitment to regulatory compliance and safety. Abbvie has achieved significant milestones, including maintaining a leading position in the global pharmaceutical market and generating substantial revenue through its innovative portfolio. The company's unique value proposition lies in its dedication to scientific excellence and patient-centric care, supported by a strong pipeline and strategic investments in research and development. Abbvie's market position is further strengthened by its global reach, collaborative partnerships, and a reputation for delivering transformative therapies.
